vs

Side-by-side financial comparison of iRhythm Holdings, Inc. (IRTC) and NETSCOUT SYSTEMS INC (NTCT). Click either name above to swap in a different company.

NETSCOUT SYSTEMS INC is the larger business by last-quarter revenue ($250.7M vs $208.9M, roughly 1.2× iRhythm Holdings, Inc.). NETSCOUT SYSTEMS INC runs the higher net margin — 22.0% vs 2.7%, a 19.3% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs -0.5%). NETSCOUT SYSTEMS INC produced more free cash flow last quarter ($59.3M vs $14.5M). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs 11.0%).

iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.

NETSCOUT Systems, Inc. is an American technology company that specializes in software observability, deep packet inspection, DDoS mitigation and AIOps. Headquartered in Westford, Massachusetts, the company was founded in 1984 by Anil Singhal and Narendra Popat, originally under the name Frontier Software.

IRTC vs NTCT — Head-to-Head

Bigger by revenue
NTCT
NTCT
1.2× larger
NTCT
$250.7M
$208.9M
IRTC
Growing faster (revenue YoY)
IRTC
IRTC
+27.7% gap
IRTC
27.1%
-0.5%
NTCT
Higher net margin
NTCT
NTCT
19.3% more per $
NTCT
22.0%
2.7%
IRTC
More free cash flow
NTCT
NTCT
$44.8M more FCF
NTCT
$59.3M
$14.5M
IRTC
Faster 2-yr revenue CAGR
IRTC
IRTC
Annualised
IRTC
25.8%
11.0%
NTCT

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
IRTC
IRTC
NTCT
NTCT
Revenue
$208.9M
$250.7M
Net Profit
$5.6M
$55.1M
Gross Margin
70.9%
81.6%
Operating Margin
1.1%
25.7%
Net Margin
2.7%
22.0%
Revenue YoY
27.1%
-0.5%
Net Profit YoY
518.5%
13.0%
EPS (diluted)
$0.18
$0.75

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRTC
IRTC
NTCT
NTCT
Q4 25
$208.9M
$250.7M
Q3 25
$192.9M
$219.0M
Q2 25
$186.7M
$186.7M
Q1 25
$158.7M
$205.0M
Q4 24
$164.3M
$252.0M
Q3 24
$147.5M
$191.1M
Q2 24
$148.0M
$174.6M
Q1 24
$131.9M
$203.4M
Net Profit
IRTC
IRTC
NTCT
NTCT
Q4 25
$5.6M
$55.1M
Q3 25
$-5.2M
$25.8M
Q2 25
$-14.2M
$-3.7M
Q1 25
$-30.7M
$18.6M
Q4 24
$-1.3M
$48.8M
Q3 24
$-46.2M
$9.0M
Q2 24
$-20.1M
$-443.4M
Q1 24
$-45.7M
$-32.4M
Gross Margin
IRTC
IRTC
NTCT
NTCT
Q4 25
70.9%
81.6%
Q3 25
71.1%
80.1%
Q2 25
71.2%
76.7%
Q1 25
68.8%
77.7%
Q4 24
70.0%
81.5%
Q3 24
68.8%
78.0%
Q2 24
69.9%
74.6%
Q1 24
66.3%
75.3%
Operating Margin
IRTC
IRTC
NTCT
NTCT
Q4 25
1.1%
25.7%
Q3 25
-4.4%
14.8%
Q2 25
-10.0%
-3.5%
Q1 25
-20.5%
9.7%
Q4 24
-2.5%
24.5%
Q3 24
-34.1%
7.4%
Q2 24
-15.5%
-265.4%
Q1 24
-28.9%
-18.2%
Net Margin
IRTC
IRTC
NTCT
NTCT
Q4 25
2.7%
22.0%
Q3 25
-2.7%
11.8%
Q2 25
-7.6%
-2.0%
Q1 25
-19.3%
9.1%
Q4 24
-0.8%
19.4%
Q3 24
-31.3%
4.7%
Q2 24
-13.6%
-254.0%
Q1 24
-34.6%
-15.9%
EPS (diluted)
IRTC
IRTC
NTCT
NTCT
Q4 25
$0.18
$0.75
Q3 25
$-0.16
$0.35
Q2 25
$-0.44
$-0.05
Q1 25
$-0.97
$0.28
Q4 24
$-0.03
$0.67
Q3 24
$-1.48
$0.13
Q2 24
$-0.65
$-6.20
Q1 24
$-1.47
$-0.43

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRTC
IRTC
NTCT
NTCT
Cash + ST InvestmentsLiquidity on hand
$583.8M
$540.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$152.7M
$1.6B
Total Assets
$1.0B
$2.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRTC
IRTC
NTCT
NTCT
Q4 25
$583.8M
$540.6M
Q3 25
$565.2M
$483.4M
Q2 25
$545.5M
$489.6M
Q1 25
$520.6M
$457.4M
Q4 24
$535.6M
$398.4M
Q3 24
$522.0M
$363.4M
Q2 24
$561.5M
$362.2M
Q1 24
$569.1M
$389.7M
Stockholders' Equity
IRTC
IRTC
NTCT
NTCT
Q4 25
$152.7M
$1.6B
Q3 25
$121.9M
$1.6B
Q2 25
$103.7M
$1.5B
Q1 25
$86.7M
$1.6B
Q4 24
$90.9M
$1.5B
Q3 24
$71.8M
$1.5B
Q2 24
$99.2M
$1.4B
Q1 24
$90.3M
$1.9B
Total Assets
IRTC
IRTC
NTCT
NTCT
Q4 25
$1.0B
$2.3B
Q3 25
$995.2M
$2.2B
Q2 25
$964.0M
$2.2B
Q1 25
$926.1M
$2.2B
Q4 24
$931.4M
$2.2B
Q3 24
$909.7M
$2.1B
Q2 24
$919.2M
$2.1B
Q1 24
$909.8M
$2.6B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRTC
IRTC
NTCT
NTCT
Operating Cash FlowLast quarter
$26.2M
$62.1M
Free Cash FlowOCF − Capex
$14.5M
$59.3M
FCF MarginFCF / Revenue
6.9%
23.6%
Capex IntensityCapex / Revenue
5.6%
1.1%
Cash ConversionOCF / Net Profit
4.70×
1.13×
TTM Free Cash FlowTrailing 4 quarters
$34.5M
$275.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRTC
IRTC
NTCT
NTCT
Q4 25
$26.2M
$62.1M
Q3 25
$34.9M
$6.7M
Q2 25
$27.7M
$73.6M
Q1 25
$-7.9M
$141.5M
Q4 24
$19.2M
$41.5M
Q3 24
$24.3M
$-3.7M
Q2 24
$11.8M
$38.4M
Q1 24
$-52.0M
$93.6M
Free Cash Flow
IRTC
IRTC
NTCT
NTCT
Q4 25
$14.5M
$59.3M
Q3 25
$20.1M
$4.4M
Q2 25
$17.3M
$71.7M
Q1 25
$-17.3M
$140.1M
Q4 24
$12.4M
$39.6M
Q3 24
$15.5M
$-4.6M
Q2 24
$3.4M
$37.2M
Q1 24
$-61.8M
$92.0M
FCF Margin
IRTC
IRTC
NTCT
NTCT
Q4 25
6.9%
23.6%
Q3 25
10.4%
2.0%
Q2 25
9.3%
38.4%
Q1 25
-10.9%
68.4%
Q4 24
7.5%
15.7%
Q3 24
10.5%
-2.4%
Q2 24
2.3%
21.3%
Q1 24
-46.8%
45.2%
Capex Intensity
IRTC
IRTC
NTCT
NTCT
Q4 25
5.6%
1.1%
Q3 25
7.7%
1.0%
Q2 25
5.6%
1.0%
Q1 25
5.9%
0.7%
Q4 24
4.2%
0.7%
Q3 24
6.0%
0.5%
Q2 24
5.7%
0.7%
Q1 24
7.4%
0.8%
Cash Conversion
IRTC
IRTC
NTCT
NTCT
Q4 25
4.70×
1.13×
Q3 25
0.26×
Q2 25
Q1 25
7.60×
Q4 24
0.85×
Q3 24
-0.41×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IRTC
IRTC

Commercial Payors$111.7M53%
Centers For Medicare And Medicaid$49.2M24%
Healthcare Institutions$34.3M16%
Non Contracted Third Party Payors$13.7M7%

NTCT
NTCT

Services$129.0M51%
Products$121.7M49%

Related Comparisons